Pfizer Inc.
TISSUE FACTOR PATHWAY INHIBITOR ANTIBODIES AND USES THEREOF

Abstract:

The invention relates to antibodies, and antigen-binding fragments thereof, that specifically bind TFPI and inhibit an activity thereof. Such antibodies and fragments are useful for treating bleeding disorders and shortening clotting time.